Bellevue Group’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-125,000
Closed -$516K 125
2016
Q1
$516K Buy
+125,000
New +$516K 0.09% 111